ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2026
Evaluating the cost-effectiveness of Everyday Life Rehabilitation (ELR) for individuals with serious mental illness in supported accommodation.
Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05056415 (Effect and Cost-effectiveness of the 'Everyday Life Rehabilitation' Intervention), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effect and Cost-effectiveness of the 'Everyday Life Rehabilitation' Intervention: a Pragmatic RCT of Integrated, Recovery-focused Rehabilitation Within Sheltered and Supported Housing Facilities for People With Psychiatric Disabilities
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEveryday Life Rehabilitation (ELR) is a recovery-oriented intervention that aims at improving residents’ quality of life through engagement in meaningful everyday activities. The intervention has been demonstrated to be effective in a randomized controlled trial (ClinicalTrials.gov: NCT05056415).
methodA cost-utility analysis (CUA) was conducted using quality-adjusted life years (QALYs) derived from ReQoL-UI as the primary outcome. Both deterministic and probabilistic sensitivity analysis was used to explore critical assumptions. A budget impact analysis was used to estimate the incremental cost of scaling up ELR in routine practice.
resultsThe intervention was found to be cost-effective compared to usual care, with an estimated incremental cost-effectiveness ratio (ICER) of 133 494 SEK (12 148 EUR) per QALY. Sensitivity analysis indicated that the findings were robust. The estimated average budget impact was estimated to be 10 118 SEK (921 EUR) per resident for one year of ELR. Overall, ELR demonstrated significant clinical benefits with minimal incremental costs.
interpretationThroughout the analysis, we have used highly conservative estimates. Despite this, the analysis concluded that the intervention has a high probability of being cost-effective. Thus, the study provides robust evidence for the value of ELR as a scalable and economically viable intervention.
Indexed as
Identifiers
41862742What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.